📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
TATVA CHINTAN PHARMA CHEM LIMITEDTATVASpecialty Chemicals
Open
1477
High
1509
Low
1460.2
Close
1489.4
Volume
87374
Exchange
nse
Time
14-Nov-2025

Outlook

Score:

2.75

Rating:

RISKY

Candlestick Pattern

CandlepatternofTatvaChintanPharmaChemis
Short Body
EstimatedStoplossofTatvaChintanPharmaChemis
1460.2
TatvaChintanPharmaChemhasa
Bullishℹ
pattern.
Formationof
Short Body
candlepatternindicatesthetrenddirectionofTatvaChintanPharmaChemis
Unpredictableℹ
.

Trend

TatvaChintanPharmaChemisin
Sideways trendℹ
.
PriceofTatvaChintanPharmaChemis
Upℹ
by

18.68

%.
Target
Buy@

825.48

Sell@

1523.04

Current@

1489.4

Volume

ThetradevolumesofTatvaChintanPharmaChemhavebecome
Deficientℹ
ThoughthevolumetrendforTatvaChintanPharmaChemappears
Bullishℹ
theparticipantsseemtobe
Weak Buyersℹ
ThetradevolumeofTatvaChintanPharmaChemis

Down

by

55.87

%

Valuation

ThecurrentmarketpriceofTatvaChintanPharmaChemis
Overvaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth836crandtotalassetsworth836cr,thebalancesheetofTatvaChintanPharmaChemis:
Balancedℹ
.
Cashflow
TatvaChintanPharmaChemhas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 23cr

.Itis
Downℹ
by

428.57

%.
22.86% i.e. ₹ 24cr earned in operatingℹ
61.9% i.e. ₹ 65cr spent in investingℹ
15.24% i.e. ₹ 16cr earned in financingℹ
0% in otherℹ
TatvaChintanPharmaChemhas
Maintainedℹ
cashflowbecausethereis

Surplus

of

₹ 7cr

.Itis
Upℹ
by

120

%.
39.52% i.e. ₹ 98cr earned in operatingℹ
48.39% i.e. ₹ 120cr spent in investingℹ
12.1% i.e. ₹ 30cr earned in financingℹ
0% in otherℹ
Income
TheincomeofTatvaChintanPharmaChemis

₹ 124cr

and

Profit

is:

₹ 9cr

TatvaChintanPharmaChemProfitisupby:

500

%andIncomeisUpby:

9.26

%
TheincomeofTatvaChintanPharmaChemis

₹ 118cr

and

Profit

is:

₹ 6cr

TatvaChintanPharmaChemProfitisupby:

100

%andIncomeisUpby:

27.06

%
TheincomeofTatvaChintanPharmaChemis

₹ 108cr

and

Loss

is:

₹ 1cr

TatvaChintanPharmaChemLossesincreasedby:

0

%andIncomeisUpby:

2.41

%
By using this site you agree to the use of cookies to deliver a better site experience.